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OBJECTIVE — Foot ulceration remains a major health problem for diabetic patients and has
a major impact on the cost of diabetes treatment. We tested a hyperspectral imaging technology
that quantiﬁes cutaneous tissue hemoglobin oxygenation and generated anatomically relevant
tissue oxygenation maps to assess the healing potential of diabetic foot ulcers (DFUs).
RESEARCH DESIGN AND METHODS — A prospective single-arm blinded study was
completedinwhich66patientswithtype1andtype2diabeteswereenrolledandfollowedover
a 24-week period. Clinical, medical, and diabetes histories were collected. Transcutaneous
oxygen tension was measured at the ankles. Superﬁcial tissue oxyhemoglobin (oxy) and deoxy-
hemoglobin(deoxy)weremeasuredwithhyperspectralimagingfromintacttissueborderingthe
ulcer. A healing index derived from oxy and deoxy values was used to assess the potential for
healing.
RESULTS — Fifty-four patients with 73 ulcers completed the study; at 24 weeks, 54 ulcers
healed while 19 ulcers did not heal. When using the healing index to predict healing, the
sensitivity was 80% (43 of 54), the speciﬁcity was 74% (14 of 19), and the positive predictive
value was 90% (43 of 48). The sensitivity, speciﬁcity, and positive predictive values increased to
86, 88, and 96%, respectively, when removing three false-positive osteomyelitis cases and four
false-negative cases due to measurements on a callus. The results indicate that cutaneous tissue
oxygenation correlates with wound healing in diabetic patients.
CONCLUSIONS — Hyperspectral imaging of tissue oxy and deoxy may predict the healing
of DFUs with high sensitivity and speciﬁcity based on information obtained from a single visit.
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D
iabetesisamajorglobaldiseasethat
affects 194 million people world-
wide and is expected to increase in
prevalence to 344 million by the year
2030 (1). One major complication of di-
abetes is foot ulceration, which occurs in
as many as 15–25% of type 1 and type 2
diabetic patients over their lifetimes (2–
4). Studies show that between 2 and 6%
of diabetic patients will develop a foot ul-
cer every year (5,6). The feet of patients
withdiabetesareatriskforulcerationdue
to a wide range of pathological condi-
tions, the major three being peripheral
neuropathy, foot deformity, and trauma,
which may be exacerbated by comorbid
peripheral vascular disease (4,7). If left
untreated, foot ulcers lead to infection
and deep-tissue necrosis (8).
Foot pathology is a major source of
morbidity in patients with diabetes and is
a leading cause of hospitalization. In-
fected and/or ischemic diabetic foot ul-
cers (DFUs) account for about 25% of all
hospital visits among patients with diabe-
tes. Previous studies have shown that a
DFU preceeds roughly 85% of all lower-
extremity amputations in patients with
diabetes (9,10), and more than 88,000
amputations are performed annually on
diabeticpatients(11).Thecosttomanage
foot disorders is estimated at several bil-
lion dollars annually (5,12). Successful
clinical management of DFUs not only
has the potential to reduce the cost of car-
ing for these patients but also to improve
quality of life by reducing comorbidities.
Current treatment options for DFUs
include ofﬂoading to reduce pressure on
the wound, wound care to prevent infec-
tions,andwounddebridementtoremove
necrotic debris and restimulate the
wound healing process (11,13,14). Even
with these measures, some wounds fail to
heal.Havingameanstoassesshealingpo-
tential may help triage wounds earlier to
more aggressive therapies, thereby avoid-
ing infections and amputations.
Clinical measurements of microvas-
cular function may be an important part
of DFU assessment (15–17). Hyperspec-
tral imaging (HSI) was developed as a
novel noninvasive diagnostic tool to
quantify tissue oxygenation and generate
anatomically relevant maps of microcir-
culatory changes seen in diabetic patients
(18). HSI generates a map of regions of
interest based on local molecular compo-
sition. With proper wavelength selection,
spatial maps of molecules such as oxyhe-
moglobin (oxy) and deoxyhemoglobin
(deoxy) can be acquired.
A pilot study of 10 type 1 diabetic
patients with 21 DFU sites showed that
HSI identiﬁed changes in tissue oxygen-
ationinthediabeticfootthatwerepredic-
tive of ulcer healing (18). The sensitivity,
speciﬁcity, and positive predictive value
of the healing index were 93, 86, and
93%, respectively. The goal of the current
study was to test the accuracy of HSI in
evaluating the healing potential of DFUs
in a large number of type 1 and 2 diabetic
patients.
RESEARCH DESIGN AND
METHODS— This was a prospective
observational study conducted at three
centers: University of California Los Ange-
les/Olive View Medical Center, Cleveland
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School of Medicine. Patients were fol-
lowed for 11 visits over 24 weeks. The
primary end point was to establish the
effectiveness of hyperspectral tissue oxy-
genationmapping(HTOM)forpredicting
whether DFUs in both type 1 and 2 dia-
beticpatientswouldheal.Healingwasde-
ﬁned as complete re-epithelialization at
24 weeks. The study was designed based
onthepreliminarydataobtainedfromthe
pilot study (18).
Inclusion criteria
Patientsaged21–85yearsdiagnosedwith
type 1 or type 2 diabetes with at least one
DFUwereeligible.Thediagnosisoftype1
and type 2 diabetes was established ac-
cording to the recommendations of the
American Diabetes Association Expert
Committee on the Diagnosis and Classiﬁ-
cation of Diabetes Mellitus (19).
Exclusion criteria
Exclusion criteria included heart failure
with consequent lower-extremity edema,
stroke or ischemic attack with residual
nerve dysfunction, uncontrolled hyper-
tension, end-stage renal disease/renal
transplant, peripheral arterial disease that
was severe enough to require surgery, se-
vere peripheral edema, any other serious
chronic disease that can affect wound
healing, treatment with antineoplastic
drugsorglucocorticoids,andpregnantor
lactating women.
Data collection
Studies were performed according to a
uniformed study protocol that was ap-
proved by the institutional review
boards at each center. After receiving a
description of the protocol and asking
questions, all patients agreeing to par-
ticipate signed an approved informed
consent form.
Medicalandfamilyhistorieswerecol-
lected from each patient. Clinical evalua-
tion included age, sex, ethnicity/race,
weight,height,BMI,systolicanddiastolic
blood pressure, ankle brachial index
(ABI), A1C, diabetes type, and diabetes
duration.Neuropathywasgradedaccord-
ing to the Neuropathic Symptom Score
and Neuropathy Disability Score (NDS)
(20,21).
Transcutaneous oxygen tension
(tcPO2)wasmeasuredattheankleofboth
legs using a transcutaneous oxygen mon-
itor (Model PF-5000; Perimed, North
Royalton, OH). The oxygen-monitoring
electrodes were coupled to the skin using
adhesiveﬁxationrings,andanelectrolytic
solution was used and set to maintain a
temperatureof44°C.Thesolutionwasal-
lowed to equilibrate for 15 min prior to
recording.
HTOM and skin temperature at the
center of the image were collected with a
commercial HSI system (OxyVu; Hy-
perMed, Burlington, MA). The HSI sys-
tem obtains multiple images at discrete
wavelengths, providing a diffuse reﬂec-
tance spectrum for each pixel in the
image. The system uses wavelengths be-
tween500and660nmtoincludeoxyand
deoxy absorption peaks. Tissue oxygen-
ation images or maps were constructed
from oxy and deoxy values determined
from each pixel in the image. Skin tem-
perature was monitored with an infrared
remote temperature sensor.
Prior to imaging, the system was cal-
ibratedtoareﬂectancecard.Patientswere
imagedsupineonastandardexamination
table or in a reclining chair and were al-
lowed to rest for 10 min to minimize sys-
temic vascular effects. Dorsal foot and
periwound tissues were imaged. A ﬁducial
target was placed to facilitate image realign-
ment correcting for patient movement.
Image registration, processing, and
quality assessment were conducted fol-
lowing the procedure. For wounds larger
than 1 cm in diameter, mean oxy and de-
oxy values were extracted from a 1-cm
radial border consisting of intact skin in
the periwound region while avoiding any
hyperkeratotic tissue. For wounds less
than 1 cm in diameter, a 0.5-cm border
was used.
Spectral decomposition was used to
extract relative values of tissue oxy and
deoxy from the diffuse reﬂectance spectra
bycomparingwithstandardtransmission
spectra from solutions (22). Oxy and de-
oxy units represent relative concentra-
tions of oxy and deoxy found in the tissue
volume measured by the HSI system (ap-
proximately the effective pixel size of the
object [0.1 mm  0.1 mm] multiplied by
the penetration depth of light into tissue
[1–2 mm in this wavelength range]).
Tissue oxygen saturation (StO2), the frac-
tion of oxygenated hemoglobin in super-
ﬁcial (predominantly subpapillary
plexus) blood vessels, was calculated as
the percentage of oxy over the sum of oxy
and deoxy.
Ulcers were classiﬁed into one of two
groups: ulcers that healed within 24
weeks or ulcers that did not heal within
24 weeks. Ulcers with complete re-
epithelialization and no exudates at the
last visit (24 weeks) were classiﬁed as
healed. A healing index was then derived
to best separate healed from nonhealed
ulcers. The healing index was calculated
as the distance between the point deﬁned
bytheoxyanddeoxyvaluesandthelinear
discriminant decision line that best sepa-
rated healed ulcers from nonhealed ul-
cers. A positive healing index was more
likely to heal, whereas a negative healing
index was more likely not to heal.
Patients received regular care by
their doctors, including ofﬂoading and
debridement when required. The treat-
ing physicians were blinded to the HSI
data. No criteria for wound size or du-
rationwereusedtoselectpatients.Clin-
ical and HSI data were captured on case
report forms and uploaded into a cen-
tral database and central ﬁle server,
respectively.
Statistics
Statistical analyses were performed by an
independent biostatistician. The data
were analyzed to detect differences be-
tweenpatientswithDFUsthathealedand
those with DFUs that did not heal. For
categoricalfactorssuchassex,differences
between the healed and nonhealed pro-
portions were compared with the 
2 test.
For continuous factors such as oxy, de-
oxy, and StO2, differences between the
means of the two groups were compared
with the Student’s t test using the more
conservative test assuming unequal vari-
ances. Values were reported as means 
SD. A P value 0.05 was considered sig-
niﬁcant. Sensitivity, speciﬁcity, and posi-
tive predictive values for healing were
calculated using standard deﬁnitions.
Linear discriminant analysis was used to
develop the threshold for separating the
healed and nonhealed groups.
RESULTS— A total of 66 type 1 and
type 2 diabetic patients (58 male and 8
female) with DFUs were enrolled in the
study. The mean age was 50 years (range
25–68). Twelve patients were excluded
from the study because they either failed
to complete the study (n  10) or re-
quired amputation prior to the 24-week
visit (n  2). The 54 patients who com-
pleted the study and presented with 73
ulcers comprise the data in this report.
Fifty-four ulcers healed while 19 ulcers
did not.
No signiﬁcant differences in demo-
graphics or clinical characteristics were
detected when comparing patients with
DFUs that healed (n  38) and patients
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Both groups were found to be well
matched for sex, age, and other patient
demographics and clinical characteristics
(Table 1). No differences were seen in the
level of neuropathy when comparing feet
withDFUsthathealedandfeetwithDFUs
that did not heal. The mean NDS was
6.7  4.9 and 7.7  3.4, respectively
(P  0.39).
The ABI was similar for limbs with
healed and nonhealed ulcers (Table 2).
All ABIs were 0.78 or greater, which is
consistent with mild peripheral arterial
disease, at most, in a few subjects. As ex-
pected for a high-risk diabetic group, a
large fraction of limbs (47%) were non-
compressible, having an ABI 1.2. Mean
tcPO2 at the ankle was 48  15 and 46 
18mmHg,respectively(P0.61).Inad-
dition, no differences were seen in the
level of tissue oxygenation. Mean StO2
taken from the dorsal foot had mean val-
ues of 53  13% for feet with DFUs that
healed and 47  12% for feet with DFUs
that did not heal (P  0.16).
WhenevaluatingmeanHTOMvalues
in the periwound area, signiﬁcant differ-
ences were observed when comparing
DFUs that healed with DFUs that did not
heal (Table 2). Higher oxy values were
noted around DFUs that healed (85  21
vs.6422,P0.0013).MeanStO2was
alsohigherinhealingulcers(669%vs.
60  10%, P  0.024). The temperature
around the ulcers was not found to be
different. A difference in ulcer size was
detected when comparing DFUs that did
not heal with DFUs that did heal. The
mean areas were 5.8  6.2 and 3.2  3.9
cm
2, respectively. However, based on the
more conservative Student’s t test using
unequalvariances,thisdifferencewasnot
signiﬁcant (P  0.10).
No major difference was seen when
comparing anatomical site distributions
for the healed ulcers with those of the
nonhealed ulcers. Twenty-nine ulcers
were located on the plantar metatarsal
phalangeal joints; 20 healed, and 9 did
not heal. Fifteen ulcers were located on
the plantar phalangeal joints; 10 healed,
and 5 did not heal. Eight ulcers were lo-
cated on the plantar arch; seven healed,
one did not heal. Seven ulcers were lo-
cated on the dorsal metatarsal phalangeal
joints; ﬁve healed, and two did not heal.
The remaining ulcers were located on the
heel (n  5), lateral foot (n  4), dorsal
phalangealjoints(n3),anddistalankle
(n  2).
HTOM as a predictor for DFU
healing
Hyperspectral and visual images from a
patientatbaselinewithaDFUthathealed
and corresponding images from a patient
withaDFUthatdidnothealareshownin
Fig.1.InthehealedDFUcase(toppanels),
the mean values for oxy, deoxy, and StO2
were75,34,and69%,respectively;while
in the nonhealed case (bottom panels), tis-
sue oxygenation was lower with values of
60, 53, and 53%, respectively.
A scatter plot of mean oxy and deoxy
values, measured from periwound tissue
for all ulcers during the initial visit, is
shown in Fig. 2A. The data were grouped
according to the healing status at 24
weeks. The linear discriminant decision
line best separating healed ulcers from
nonhealedulcersisshown.HTOMpoints
to the left of the decision line best repre-
sent ulcers that did not heal and would
have a negative healing index, while
pointstotherightofthedecisionlinebest
represent ulcers that did heal and would
have a positive healing index. The mean
healing index for ulcers that did not heal
in 24 weeks is signiﬁcantly different from
that for ulcers that healed within 24
weeks (0.15 vs. 0.15, P  0.0001).
Aplotofthehealingindexisshownin
Fig. 2B. The healing index indicated that
the sensitivity for healing was 80% (43 of
54), the speciﬁcity was 74% (14 of 19),
Table 1—Patient demographics and clinical characteristics
Patients with
healed ulcers
Patients with any
nonhealed ulcers P
n 38 16
Age (years) 51 (34–68) 52 (25–63) 0.73
Sex (m/f) 35/3 14/2 0.34
Diabetes (type 1/type 2) 15/23 8/8 0.19
Diabetes duration (years) 13  10 12  8 0.77
A1C (%) 9.7  2.6 9.5  2.4 0.83
BMI (kg/m
2) 34  10 31  12 0.41
Systolic BP (mmHg) 135  24 142  21 0.28
Diastolic BP (mmHg) 76  13 79  9 0.38
NSS 5.3  3.3 4.9  3.0 0.65
NDS 7.7  3.4 6.7  4.9 0.39
Data are n, means  SD, and median (range). BP, blood pressure; NSS, Neuropathy Symptom Score.
Table 2—Lower-limb assessment
Foot with nonhealed
ulcers (n  19)
Foot with healed
ulcers (n  54) P
At the ankle
ABI 0.4 0 0 —
ABI 0.4–0.69 0 0 —
ABI 0.70–0.89 3 4 —
ABI 0.90–1.19 6 16 —
ABI 1.2 5 19 —
ABI, NR 5 15 —
tcPO2 (mmHg) 46  16 48  15 0.61
At the foot
Oxy (dorsum) (AU) 42  18 44  19 0.72
Deoxy (dorsum) (AU) 44  13 37  13 0.081
StO2 (dorsum) (%) 47  12 53  13 0.16
At the ulcer border
Ulcer size (cm
2) 5.8  6.2 3.2  3.9 0.10
Oxy (AU) 64  22 85  21 0.0013
Deoxy (AU) 41  12 44  14 0.47
StO2 (%) 60  10 66  9 0.024
Healing index 0.15  18 0.15  19 0.0001
Temperature (
oC) 33  33 3  3 0.83
Data are n and means  SD. Data in bold are statistically signiﬁcant. AU, arbitary units; NR, not recorded.
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(43 of 48). The sigmoidal line represents
the probability of healing based on the
healingindexfromthetwogroups.Ofthe
ﬁve patients with ulcers that did not heal
and had a positive healing index, three
had underlying osteomyelitis and one re-
fused to wear proper foot gear. The re-
maining 70 ulcer sites did not have any
clinical signs of osteomyelitis. Of the 10
ulcers that did heal and had a negative
healing index, the tissue surrounding 4 of
the ulcers were callused.
When selecting borders around the
wound, the thickness of the border was
important. The ability to separate healing
fromnonhealingulcerswasoptimalwhen
using a border thickness between 0.5 and
1 cm. Reduced discrimination was ob-
served when increasing the border thick-
ness to 2 cm.
CONCLUSIONS — In this multi-
center 24-week study, we show that
HTOM provides a local assessment of mi-
crovascularoxygenationstatusthatispre-
dictive of ulcer healing in type 1 and type
2 diabetic patients. HTOM offers high
sensitivity (81%) and speciﬁcity (74%) in
determining healing potential. Addition-
ally, the data show that HSI can assess
healing capacity with a 90% positive pre-
dictivevalue.Higherulcerhealingpredic-
tions are possible if care is taken to avoid
evaluating ulcers with underlying osteo-
myelitis and those with overlying cal-
luses. The sensitivity, speciﬁcity, and
positive predictive values increase to 86,
88, and 96%, respectively, when remov-
ingthreefalse-positiveosteomyelitiscases
and four false-negative cases due to mea-
surements on calluses.
Theresultsofthisstudynotonlycon-
ﬁrm preliminary results obtained in an
earlier pilot study (18) but also ﬁrmly es-
tablish that HTOM serves as a clinically
relevant technique for predicting DFU
healing based on an evaluation of 54 pa-
tients and 73 ulcers. HTOM allows the
physician to identify DFUs at risk of not
healingmuchearlierbecausedataarecol-
lected and assessed from the ﬁrst visit
(i.e., without having to wait for 6
months). These results demonstrate that
HSI can measure tissue oxygenation with
spatial resolutions of 100 microns with-
out coming into contact with the patient’s
foot.
Adequate tissue microvascular perfu-
sion is an essential element for wound
healing. The HSI system used in this
study was designed to evaluate tissue ox-
ygenationatthesuperﬁcialmicrovascular
level. HTOM values predicted healing
status better when evaluating tissue
close to the wound margins, thus dem-
onstrating periwound changes in mi-
crovessels that can be used for assessing
the healing capacity of a DFU. Healed
DFUsdemonstrateincreasedmicrovascu-
lar oxygenation as evidenced by an in-
crease in oxy and StO2 when compared
with nonhealed DFUs. A similar increase
in StO2 has been noted previously with
another independently established tech-
nique (23).
Based on the NDS, 65% of the pa-
tients had moderate to severe foot neu-
ropathy (NDS 5). HTOM taken from
the dorsal foot showed that 93% of pa-
tients had a StO2 that was greater than
30%,while87%ofpatientshadatcPO2at
theanklethatwasgreaterthan30mmHg.
Both oxygenation techniques indicate the
foot was reasonably well oxygenated in
the basal state, and differences between
healing and nonhealing ulcers only sur-
facedoncethewoundwaspresentandthe
tissue was either able or not able to re-
spond to the injury.
In summary, HTOM can accurately
predict wound healing in advance e.g.,
several months before the wound heals.
Physicians are now able to identify which
DFUsareatriskfordelayedhealingbased
on reduced oxygenation levels resulting
Figure1—VisibleandhyperspectralimageofahealingDFUtakenwiththeHTOMsystem.ThetoppanelsshowahealedDFUcase.HTOMvalues
are 75, 34, and 69% for oxy, deoxy, and StO2, respectively. The bottom panels show a nonhealed DFU case. HTOM values are 60, 53, and 53% for
oxy,deoxy,andStO2,respectively.Tissueoxygenationishigherinthehealedulcerasseenbythemorepurplishtonecomparedwiththemorecyan/green
tone. Mean oxy and deoxy values were determined for each ulcer from an approximate 1-cm–thick band drawn within the periwound area.
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increase oxygen delivery to tissue.
Based on these results assessing micro-
vascular perfusion, HTOM may be used
in three main areas of patient care: DFU
management, surgical planning, and
monitoring of therapy. The addition of
quantitativeoxygenationinformationto
the current available tools and treat-
ment could allow for more targeted
therapyandcouldpotentiallyaccelerate
current case resolutions.
Ultimately, HTOM has the potential
to screen for lower-extremity complica-
tions due to diabetes. This is based on the
ability of HTOM to quantify risk in a spe-
ciﬁc area of tissue and the ability to ob-
serve ischemic complications before they
would otherwise be visible to the naked
eye. HTOM provides the diabetes care-
giver with the information necessary to
treat and monitor foot complications
fasterandmorespeciﬁcallythanwouldbe
possible with current available methods,
which lack adequate sensitivity, speciﬁc-
ity, and spatial localization to assess the
microvascular status of the foot.
Figure2—A:OxyanddeoxyvaluesforhealedandnonhealedDFUs.Thediagonalsolidlinerepresentsthedecisionlineforahealingalgorithmbased
onoxyanddeoxyvalues.Ninetypercentofpointslyingtotherightofthelinehealed.Thediagonaldashedlinerepresentsaseconddecisionlinewhere
87% of the points (seven of eight excluding calluses) lying to the left of the line did not heal. B: Probability of healing based on HTOM healing index
for healed and nonhealed DFUs. An ulcer with a positive healing index has a higher likelihood to heal.  , Ulcers with underlying osteomyelitis that
did not heal;  , ulcers that did not heal at 24 weeks; E, ulcers that healed and were surrounded by callus; U, ulcers that healed at 24 weeks. arb,
arbitrary.
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